Notable
ATX-898 · Advanced Solid Tumors
Primary completion pushed from Oct 28, 2028 to Oct 28, 2029
Also in this update: Recruitment opened; Trial sites expanded: 0 → 6 locations
Antares Therapeutics, IncPhase 1/2 NCT07767474 Registry history of NCT07767474 on ClinicalTrials.gov (opens the registry)